Evidence map›Paper›PMID 39348886›Full record

ArticleACS applied materials & interfaces2024

Fluidic Interface for Surface-based DNA Origami Studies.

Miguel García-Chamé, Ivy Mayer, Leonie Schneider, Christof M Niemeyer, Carmen M Domínguez

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Clustering of Membrane Receptors: Insights from DNA Origami-Based Approaches.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miguel García-ChaméInstitute for Biological Interfaces (IBG-1), Karlsruhe Institute of Technology (KIT), 76344 Eggenstein-Leopoldshafen, Germany.
Ivy MayerInstitute for Biological Interfaces (IBG-1), Karlsruhe Institute of Technology (KIT), 76344 Eggenstein-Leopoldshafen, Germany.ORCID 0000-0002-6868-9719
Leonie SchneiderInstitute for Biological Interfaces (IBG-1), Karlsruhe Institute of Technology (KIT), 76344 Eggenstein-Leopoldshafen, Germany.ORCID 0000-0002-3772-1480
Christof M NiemeyerInstitute for Biological Interfaces (IBG-1), Karlsruhe Institute of Technology (KIT), 76344 Eggenstein-Leopoldshafen, Germany.
Carmen M DomínguezInstitute for Biological Interfaces (IBG-1), Karlsruhe Institute of Technology (KIT), 76344 Eggenstein-Leopoldshafen, Germany.ORCID 0000-0002-0918-5473

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditionally, the use of DNA origami nanostructures (DONs) to study early cell signaling processes has been conducted using standard laboratory equipment with DONs typically utilized in solution. Surface-based technologies simplify the microscopic analysis of cells treated with DON agents by anchoring them to solid substrates, thus avoiding the complications of receptor-mediated endocytosis. A robust microfluidic platform for real-time monitoring and precise functionalization of surfaces with DONs was developed here. The combination of controlled flow conditions with an upright total internal reflection fluorescence microscope enabled the kinetic analysis of the immobilization of DONs on DNA-functionalized surfaces. The results revealed that DON morphology and binding tags influence the binding kinetics and that DON hybridization on surfaces is more effective in microfluidic devices with larger-than-standard dimensions, addressing the low diffusivity challenge of DONs. The platform enabled the decoration of DONs with protein-binding ligands and in situ investigation of ligand occupancy on DONs to produce high-quality bioactive surfaces. These surfaces were used to recruit and activate the epidermal growth factor receptor (EGFR) through clustering in the membranes of living cancer cells (MCF-7) using an antagonistic antibody (Panitumumab). The activation was quantified depending on the interligand distances of the EGFR-targeting antibody.

Indexed as

DNAErbB ReceptorsNanostructuresHumansMCF-7 CellsMicrofluidic Analytical TechniquesSurface PropertiesDNAEGFR protein, humanErbB ReceptorsDNA nanostructuresepidermal growth factor receptormicrofluidicsmicropatterningPanitumumabsurfaces

Identifiers

PMID39348886
PMCPMC11472258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.